Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 20

1.

Acute pancreatitis in patients with pancreatic cancer: Timing of surgery and survival duration.

Li S, Tian B.

Medicine (Baltimore). 2017 Jan;96(3):e5908. doi: 10.1097/MD.0000000000005908.

2.

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement.

Lee JH, Kang CM, Bang SM, Choi JY, Seong JS, Hwang HK, Choi SH, Lee WJ.

Medicine (Baltimore). 2015 Aug;94(31):e1233. doi: 10.1097/MD.0000000000001233.

3.

Improving outcomes in pancreatic cancer: key points in perioperative management.

Alamo JM, Marín LM, Suarez G, Bernal C, Serrano J, Barrera L, Gómez MA, Muntané J, Padillo FJ.

World J Gastroenterol. 2014 Oct 21;20(39):14237-45. doi: 10.3748/wjg.v20.i39.14237. Review.

4.

Borderline resectable pancreatic cancer: definitions and management.

Lopez NE, Prendergast C, Lowy AM.

World J Gastroenterol. 2014 Aug 21;20(31):10740-51. doi: 10.3748/wjg.v20.i31.10740. Review.

5.

Anticoagulation policy after venous resection with a pancreatectomy: a systematic review.

Chandrasegaram MD, Eslick GD, Lee W, Brooke-Smith ME, Padbury R, Worthley CS, Chen JW, Windsor JA.

HPB (Oxford). 2014 Aug;16(8):691-8. doi: 10.1111/hpb.12205. Review.

6.

Radiographic tumor-vein interface as a predictor of intraoperative, pathologic, and oncologic outcomes in resectable and borderline resectable pancreatic cancer.

Tran Cao HS, Balachandran A, Wang H, Nogueras-González GM, Bailey CE, Lee JE, Pisters PW, Evans DB, Varadhachary G, Crane CH, Aloia TA, Vauthey JN, Fleming JB, Katz MH.

J Gastrointest Surg. 2014 Feb;18(2):269-78; discussion 278. doi: 10.1007/s11605-013-2374-3.

7.

Histologic tumor involvement of superior mesenteric vein/portal vein predicts poor prognosis in patients with stage II pancreatic adenocarcinoma treated with neoadjuvant chemoradiation.

Wang J, Estrella JS, Peng L, Rashid A, Varadhachary GR, Wang H, Lee JE, Pisters PW, Vauthey JN, Katz MH, Gomez HF, Evans DB, Abbruzzese JL, Fleming JB, Wang H.

Cancer. 2012 Aug 1;118(15):3801-11. doi: 10.1002/cncr.26717.

8.

Radiologic and intraoperative detection of need for mesenteric vein resection in patients with adenocarcinoma of the head of the pancreas.

Porembka MR, Hawkins WG, Linehan DC, Gao F, Ma C, Brunt EM, Strasberg SM.

HPB (Oxford). 2011 Sep;13(9):633-42. doi: 10.1111/j.1477-2574.2011.00343.x.

9.

Vascular invasion in pancreatic cancer: Imaging modalities, preoperative diagnosis and surgical management.

Buchs NC, Chilcott M, Poletti PA, Buhler LH, Morel P.

World J Gastroenterol. 2010 Feb 21;16(7):818-31. Review.

10.

Portal vein resection during pancreaticoduodenectomy for cancer.

Khan AZ, Smith AM, Irving GR, Cameron I.

Ann R Coll Surg Engl. 2009 Mar;91(2):95-9. doi: 10.1308/003588409X392045. No abstract available.

11.
12.

Therapeutic anticoagulant does not modify thromboses rate vein after venous reconstruction following pancreaticoduodenectomy.

Ouaïssi M, Sielezneff I, Pirro N, Bon Mardion R, Chaix JB, Merad A, Berdah S, Moutardier V, Cresti S, Emungania O, Anderson L, Christian B, Bernard S.

Gastroenterol Res Pract. 2008;2008:896320. doi: 10.1155/2008/896320.

13.

Results of vascular resections during pancreatectomy from two European centres: an analysis of survival and disease-free survival explicative factors.

Adham M, Mirza DF, Chapuis F, Mayer AD, Bramhall SR, Coldham C, Baulieux J, Buckels J.

HPB (Oxford). 2006;8(6):465-73. doi: 10.1080/13651820600839944.

14.

Preoperative staging and evaluation of resectability in pancreatic ductal adenocarcinoma.

Andersson R, Vagianos CE, Williamson RC.

HPB (Oxford). 2004;6(1):5-12. doi: 10.1080/13651820310017093.

15.

Preoperative biliary drainage for periampullary tumors causing obstructive jaundice; DRainage vs. (direct) OPeration (DROP-trial).

van der Gaag NA, de Castro SM, Rauws EA, Bruno MJ, van Eijck CH, Kuipers EJ, Gerritsen JJ, Rutten JP, Greve JW, Hesselink EJ, Klinkenbijl JH, Rinkes IH, Boerma D, Bonsing BA, van Laarhoven CJ, Kubben FJ, van der Harst E, Sosef MN, Bosscha K, de Hingh IH, Th de Wit L, van Delden OM, Busch OR, van Gulik TM, Bossuyt PM, Gouma DJ.

BMC Surg. 2007 Mar 12;7:3.

16.

Oncological problems in pancreatic cancer surgery.

Nakao A, Fujii T, Sugimoto H, Kanazumi N, Nomoto S, Kodera Y, Inoue S, Takeda S.

World J Gastroenterol. 2006 Jul 28;12(28):4466-72. Review.

17.

Evidence-based pancreatic head resection for pancreatic cancer and chronic pancreatitis.

Schäfer M, Müllhaupt B, Clavien PA.

Ann Surg. 2002 Aug;236(2):137-48. Review.

18.

Pancreatic adenocarcinoma: why and when should it be resected?

Ravichandran D, Johnson CD.

Postgrad Med J. 1997 Aug;73(862):469-75. Review.

19.

Surgery for periampullary and pancreatic carcinoma: a Liverpool experience.

Kingsnorth AN.

Ann R Coll Surg Engl. 1997 Jul;79(4):259-63.

20.

Isolated portal vein involvement in pancreatic adenocarcinoma. A contraindication for resection?

Harrison LE, Klimstra DS, Brennan MF.

Ann Surg. 1996 Sep;224(3):342-7; discussion 347-9.

Items per page

Supplemental Content

Support Center